Get the Stockscreener App
70.81
3.00%
-2.19
After Hours:
70.81
Solventum Corp stock is traded at $70.81, with a volume of 1.09M.
It is down -3.00% in the last 24 hours and down -6.52% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$73.00
Open:
$72
24h Volume:
1.09M
Relative Volume:
1.02
Market Cap:
$12.28B
Revenue:
$8.42B
Net Income/Loss:
$1.52B
P/E Ratio:
8.1512
EPS:
8.6871
Net Cash Flow:
$56.00M
1W Performance:
-3.55%
1M Performance:
-6.52%
6M Performance:
-0.83%
1Y Performance:
-11.66%
1-Day Range:
$70.56
$72.16
1-Week Range:
$70.56
$77.89
52-Week Range:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
70.81 | 12.66B | 8.42B | 1.52B | 56.00M | 8.6871 |
|
ISRG
Intuitive Surgical Inc
|
497.42 | 176.23B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
174.21 | 50.22B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
83.08 | 41.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.28 | 37.50B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.39 | 37.20B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-26 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-20-26 | Upgrade | Mizuho | Neutral → Outperform |
| Dec-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
Solventum Stock: Improvements Come Slow (NYSE:SOLV) - Seeking Alpha
UBS Adjusts Solventum Price Target to $82 From $79, Maintains Neutral Rating - marketscreener.com
Solventum Corporation (SOLV) Stock Analysis: A 21% Upside Potential Amidst Mixed Signals - DirectorsTalk Interviews
Solventum Corporation $SOLV Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Solventum Earnings Call Balances Growth With Headwinds - TipRanks
Solventum Sets Confident Course with Strategic Overhaul and 2026 Guidance - AD HOC NEWS
SOLV PE Ratio & Valuation, Is SOLV Overvalued - Intellectia AI
Andra AP fonden Has $8.04 Million Holdings in Solventum Corporation $SOLV - MarketBeat
Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks - TipRanks
Solventum Q4 Earnings Call Highlights - Yahoo Finance
Is It Time To Reassess Solventum (SOLV) After The 3M Separation? - simplywall.st
US Bancorp DE Has $31.04 Million Stock Position in Solventum Corporation $SOLV - MarketBeat
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen - MarketBeat
Piper Sandler reiterates Solventum stock rating on revenue growth By Investing.com - Investing.com South Africa
Solventum (SOLV) One Off US$1.5b Gain Raises Questions For Bullish Margin Narratives - simplywall.st
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - Yahoo Finance
Solventum Corp. stock falls Friday, underperforms market - MarketWatch
SOLV: BTIG Reiterates 'Buy' Rating with Price Target Unchanged a - GuruFocus
Solventum Dental Solutions Sales Grow 8.6% in Q4 - Orthodontic Products
Solventum Corp SEC 10-K Report - TradingView
Solventum (NYSE:SOLV) Given New $83.00 Price Target at Wells Fargo & Company - MarketBeat
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down - Zacks Investment Research
Solventum Corp (SOLV) Shares Gap Down to $74.47 on Feb 27 - GuruFocus
Solventum Beat Wall Street Earnings Estimates. The Stock Is Down. - Barron's
Solventum (SOLV) Maintains Overweight Rating with Raised Price T - GuruFocus
Solventum (NYSE:SOLV) Stock Price Expected to Rise, KeyCorp Analyst Says - MarketBeat
Solventum (NYSE:SOLV) Given Buy Rating at BTIG Research - MarketBeat
Piper Sandler reiterates Solventum stock rating on revenue growth - Investing.com
Solventum Q4 FY25 slides: organic growth solid despite earnings miss By Investing.com - Investing.com India
Solventum Beat Wall Street Earnings Estimates. The Stock Falls. - Barron's
KeyBanc Adjusts Price Target on Solventum to $99 From $97, Maintains Overweight Rating - marketscreener.com
Wells Fargo Adjusts Price Target on Solventum to $83 From $86, Maintains Equalweight Rating - marketscreener.com
Jefferies Adjusts Price Target on Solventum to $84 From $75, Maintains Hold Rating - marketscreener.com
Solventum exceeds earnings estimates in first year as solo company - MassDevice
Solventum (NYSE:SOLV) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS - MarketBeat
Solventum: Q4 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Solventum Q4 2025 misses EPS expectations By Investing.com - Investing.com South Africa
Solventum Q4 FY25 slides: organic growth solid despite earnings miss - Investing.com
Earnings call transcript: Solventum Q4 2025 misses EPS expectations - Investing.com
Solventum Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Solventum (NYSE:SOLV) Updates FY 2026 Earnings Guidance - MarketBeat
SOLVENTUM ($SOLV) Releases Q4 2025 Earnings - Quiver Quantitative
Solventum (SOLV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Solventum's (NYSE:SOLV) Q4 CY2025 Sales Top Estimates - Finviz
Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates - Barchart.com
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Solventum Corporation 2025 Q4ResultsEarnings Call Presentation (NYSE:SOLV) 2026-02-26 - Seeking Alpha
Solventum Q4 Earnings Rise, Revenue Declines; Guidance Set - marketscreener.com
Solventum Corporation Announces Increase In Q4 Income - Nasdaq
Solventum (SOLV) Q4 2025 Earnings Call Transcript - The Globe and Mail
Solventum Q4 Earnings Summary & Key Takeaways - Benzinga
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.38%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):